Ballentine Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.71M | Sell |
6,690
-619
| -8% | -$251K | 0.04% | 152 |
|
|
2025
Q1 | $3.64M | Sell |
7,309
-147
| -2% | -$73.1K | 0.06% | 109 |
|
|
2024
Q4 | $3.88M | Sell |
7,456
-804
| -10% | -$418K | 0.07% | 100 |
|
|
2024
Q3 | $5.11M | Buy |
8,260
+543
| +7% | +$336K | 0.09% | 83 |
|
|
2024
Q2 | $4.27M | Sell |
7,717
-86
| -1% | -$47.6K | 0.08% | 88 |
|
|
2024
Q1 | $4.54M | Buy |
7,803
+864
| +12% | +$502K | 0.09% | 81 |
|
|
2023
Q4 | $3.68M | Sell |
6,939
-1,950
| -22% | -$1.04M | 0.08% | 93 |
|
|
2023
Q3 | $4.5M | Buy |
8,889
+1,733
| +24% | +$877K | 0.11% | 75 |
|
|
2023
Q2 | $3.73M | Buy |
7,156
+295
| +4% | +$154K | 0.09% | 82 |
|
|
2023
Q1 | $3.95M | Buy |
6,861
+225
| +3% | +$130K | 0.1% | 80 |
|
|
2022
Q4 | $3.65M | Buy |
6,636
+573
| +9% | +$316K | 0.11% | 73 |
|
|
2022
Q3 | $3.08M | Buy |
6,063
+582
| +11% | +$295K | 0.11% | 74 |
|
|
2022
Q2 | $2.98M | Buy |
5,481
+158
| +3% | +$85.8K | 0.11% | 72 |
|
|
2022
Q1 | $3.14M | Buy |
5,323
+52
| +1% | +$30.7K | 0.1% | 77 |
|
|
2021
Q4 | $3.52M | Buy |
5,271
+334
| +7% | +$223K | 0.11% | 75 |
|
|
2021
Q3 | $2.82M | Buy |
4,937
+19
| +0.4% | +$10.9K | 0.1% | 79 |
|
|
2021
Q2 | $2.48M | Buy |
4,918
+110
| +2% | +$55.5K | 0.09% | 80 |
|
|
2021
Q1 | $2.19M | Buy |
4,808
+181
| +4% | +$82.6K | 0.08% | 87 |
|
|
2020
Q4 | $2.16M | Sell |
4,627
-557
| -11% | -$260K | 0.09% | 82 |
|
|
2020
Q3 | $2.29M | Sell |
5,184
-101
| -2% | -$44.6K | 0.1% | 76 |
|
|
2020
Q2 | $1.91M | Sell |
5,285
-528
| -9% | -$191K | 0.09% | 87 |
|
|
2020
Q1 | $1.65M | Buy |
5,813
+62
| +1% | +$17.6K | 0.1% | 87 |
|
|
2019
Q4 | $1.87M | Sell |
5,751
-30
| -0.5% | -$9.75K | 0.08% | 97 |
|
|
2019
Q3 | $1.68M | Sell |
5,781
-88
| -1% | -$25.6K | 0.08% | 104 |
|
|
2019
Q2 | $1.72M | Buy |
5,869
+623
| +12% | +$183K | 0.08% | 100 |
|
|
2019
Q1 | $1.44M | Buy |
5,246
+60
| +1% | +$16.4K | 0.07% | 96 |
|
|
2018
Q4 | $1.16M | Sell |
5,186
-101
| -2% | -$22.6K | 0.07% | 103 |
|
|
2018
Q3 | $1.29M | Buy |
5,287
+355
| +7% | +$86.6K | 0.07% | 106 |
|
|
2018
Q2 | $1.02M | Buy |
4,932
+289
| +6% | +$59.9K | 0.06% | 116 |
|
|
2018
Q1 | $959K | Buy |
4,643
+93
| +2% | +$19.2K | 0.05% | 115 |
|
|
2017
Q4 | $864K | Buy |
4,550
+119
| +3% | +$22.6K | 0.05% | 135 |
|
|
2017
Q3 | $838K | Sell |
4,431
-41
| -0.9% | -$7.75K | 0.05% | 142 |
|
|
2017
Q2 | $801K | Sell |
4,472
-154
| -3% | -$27.6K | 0.06% | 146 |
|
|
2017
Q1 | $711K | Sell |
4,626
-143
| -3% | -$22K | 0.05% | 95 |
|
|
2016
Q4 | $673K | Buy |
4,769
+554
| +13% | +$78.2K | 0.05% | 87 |
|
|
2016
Q3 | $671K | Sell |
4,215
-129
| -3% | -$20.5K | 0.05% | 78 |
|
|
2016
Q2 | $643K | Buy |
4,344
+16
| +0.4% | +$2.37K | 0.05% | 90 |
|
|
2016
Q1 | $613K | Buy |
4,328
+282
| +7% | +$39.9K | 0.05% | 93 |
|
|
2015
Q4 | $574K | Buy |
4,046
+60
| +2% | +$8.51K | 0.06% | 85 |
|
|
2015
Q3 | $488K | Buy |
3,986
+7
| +0.2% | +$857 | 0.05% | 89 |
|
|
2015
Q2 | $516K | Buy |
3,979
+18
| +0.5% | +$2.33K | 0.05% | 86 |
|
|
2015
Q1 | $532K | Sell |
3,961
-43
| -1% | -$5.78K | 0.05% | 84 |
|
|
2014
Q4 | $502K | Buy |
+4,004
| New | +$502K | 0.06% | 86 |
|